ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for ADVANCED CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy cocktail tested for tough kidney cancer
Disease control TerminatedThis early-phase trial tested a combination of two immunotherapy drugs—aldesleukin (IL-2) and pembrolizumab—in 6 people with advanced kidney cancer that had spread. The goal was to find the safest dose and see if the combo could shrink tumors. The study was stopped early, so resu…
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug combo tested for advanced kidney cancer – study stopped early
Disease control TerminatedThis study tested a combination of two drugs, sitravatinib and nivolumab, in 15 people with advanced kidney cancer that had spread and worsened after prior treatments. The goal was to see if the combo could shrink tumors or slow the disease. The study was terminated early, so res…
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC